Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.814.86-11.939.9461.19

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 19.81 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.81
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.81
307.61
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,666.4 Cr -3.7% -5.8% 16.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,402.0 Cr 1.2% -0.9% -1.8% Stock Analytics
DIVIS LABORATORIES ₹164,277.0 Cr 2.7% -3.8% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,140.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹107,398.0 Cr -0.1% -8.2% -8.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,378.0 Cr 2.7% 7.1% 2.8% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

-3.7%

-5.8%

16.5%

SENSEX

0.4%

-0.2%

6.9%


You may also like the below Video Courses